» Articles » PMID: 37109432

Non-Viral Carriers for Nucleic Acids Delivery: Fundamentals and Current Applications

Overview
Journal Life (Basel)
Specialty Biology
Date 2023 Apr 28
PMID 37109432
Authors
Affiliations
Soon will be listed here.
Abstract

Over the past decades, non-viral DNA and RNA delivery systems have been intensively studied as an alternative to viral vectors. Despite the most significant advantage over viruses, such as the lack of immunogenicity and cytotoxicity, the widespread use of non-viral carriers in clinical practice is still limited due to the insufficient efficacy associated with the difficulties of overcoming extracellular and intracellular barriers. Overcoming barriers by non-viral carriers is facilitated by their chemical structure, surface charge, as well as developed modifications. Currently, there are many different forms of non-viral carriers for various applications. This review aimed to summarize recent developments based on the essential requirements for non-viral carriers for gene therapy.

Citing Articles

Topical delivery of siRNA to psoriatic skin model using high molecular weight chitosan derivatives: In vitro and in vivo studies.

Martinez Junior A, Ruiz T, Vilamaior P, Tiera V, Taboga S, Tiera M Drug Deliv Transl Res. 2025; .

PMID: 39907973 DOI: 10.1007/s13346-025-01800-4.


T14diLys/DOPE Liposomes: An Innovative Option for siRNA-Based Gene Knockdown?.

Meinhard S, Erdmann F, Lucas H, Krabbes M, Kruger S, Wolk C Pharmaceutics. 2025; 17(1).

PMID: 39861674 PMC: 11769127. DOI: 10.3390/pharmaceutics17010025.


Advances in RNA-Based Therapeutics: Challenges and Innovations in RNA Delivery Systems.

Liu Y, Ou Y, Hou L Curr Issues Mol Biol. 2025; 47(1).

PMID: 39852137 PMC: 11763986. DOI: 10.3390/cimb47010022.


Amphiphilic dynamic covalent polymer vectors of siRNA.

Coll J, Trousselier P, Pawar S, Bessin Y, Lichon L, Leblond Chain J Chem Sci. 2025; 16(5):2413-2419.

PMID: 39790989 PMC: 11707677. DOI: 10.1039/d4sc07668k.


Advancing Breast Cancer Therapeutics: Targeted Gene Delivery Systems Unveiling the Potential of Estrogen Receptor-Targeting Ligands.

Lee J, Kim Y, Kim E, Jang M, Park S Biomater Res. 2024; 28:0087.

PMID: 39319107 PMC: 11420687. DOI: 10.34133/bmr.0087.


References
1.
Lungwitz U, Breunig M, Blunk T, Gopferich A . Polyethylenimine-based non-viral gene delivery systems. Eur J Pharm Biopharm. 2005; 60(2):247-66. DOI: 10.1016/j.ejpb.2004.11.011. View

2.
Guo Y, Hu Y, Zheng X, Cao X, Li Q, Wei Z . Self-assembled peptide nanoparticles with endosome escaping permits for co-drug delivery. Talanta. 2020; 221:121572. DOI: 10.1016/j.talanta.2020.121572. View

3.
Hobel S, Aigner A . Polyethylenimines for siRNA and miRNA delivery in vivo. Wiley Interdiscip Rev Nanomed Nanobiotechnol. 2013; 5(5):484-501. DOI: 10.1002/wnan.1228. View

4.
Filmus J, Capurro M, Rast J . Glypicans. Genome Biol. 2008; 9(5):224. PMC: 2441458. DOI: 10.1186/gb-2008-9-5-224. View

5.
Lazebnik M, Keswani R, Pack D . Endocytic Transport of Polyplex and Lipoplex siRNA Vectors in HeLa Cells. Pharm Res. 2016; 33(12):2999-3011. DOI: 10.1007/s11095-016-2022-1. View